期刊文献+

嗜铬细胞瘤转移的临床影响因素研究 被引量:1

Prognostic factors for metastasis of pheochromocytomas
原文传递
导出
摘要 收集和分析2002年至2012年上海市瑞金医院内分泌科收治的274例嗜铬细胞瘤患者的临床资料,通过单因素和多因素非转移生存分析探究嗜铬细胞瘤转移的影响因素。结果提示原发肿瘤直径≥6cm和肾上腺外患者非转移生存时间显著降低(P〈0.05)。直径和部位的转移风险比(HR)为1.14和3.38。原发直径和部位是转移的独立影响因素。 Clinical data of 274 cases diagnosed as pheochromocytomas from 2002 to 2012 in Ruijin Hospital were analyzed in this study. Univariate and multivariate analyses of metastasis-free survival were applied. The results suggested that metastatic-free survival of patients with primary tumor 6 cm or more in diameter and extra-adrenal location was significantly lower( P〈0.05 ). The hazard ratio for metastasis in larger tumor size and extra-adrenal group was 1.14 and 3.38 respectively. Primary tumor size and location were independent risk factors for metastases.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2015年第7期596-598,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 嗜铬细胞瘤 转移 COX回归 Pheochromoeytomas Metastasis Cox regression
  • 相关文献

参考文献19

  • 1Lloyd R, DE Lellis R, Heitz P, et al. World Health Organization classification of tumours: pathology and genetics of tumours of the endocrine organs [M]. International Agency for Research on Cancer (IARC) Press, Lyon, 2004.
  • 2Harari A, Inabnet III WB. Malignant pheochromocytoma: A review [J]. Am J Surg, 2011,201 (5) :700-708.
  • 3Nomura K, Kimura H, Shimizu S, et al. Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy [ J ]. J Clin Endocrinol Metab, 2009,94 ( 8 ) :2850-2856.
  • 4Lai EW, Perera SM, Havekes B, et al. Gender-related differences in the clinical presentation of malignant and benign pheochromocytoma [ J]. Endocrine, 2008,34 ( 1-3 ) :96-100.
  • 5Ayala-Ramirez M, Feng L, Johnson MM, et al. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary" tumor size and primary tumor location as prognostic indicators [ J ]. J Clin Endocrinol Metab, 2011, 96(3) :717-725.
  • 6Strong VE, Kennedy T, Al-ahmadie H, et al. Prognostic indicators of malignacy in adrenal pheochromocytnmas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis[J]. Surgery, 2008, 143(6) :759.
  • 7Zelinka T, Musil Z, Duskova J, et al. Metastatic pheochromocytoma : Does the size and age matter [ J ] ? Eur J Clin Invest, 2011,41 ( 10 ) : 1121-1128.
  • 8Feng F, Zhu Y, Wang X, et al. Predictive factors for malignant pheochromocytoma: analysis of 136 patients [ J ]. J Urol, 2011,185 (5) :1583-1590.
  • 9姜蕾,王卫庆,张军妮,戴蒙,苏颋为,宁光.高效液相色谱电化学法测定血间甲肾上腺素类物质方法的建立及临床应用[J].中华内分泌代谢杂志,2004,20(6):561-563. 被引量:23
  • 10苏颋为,王卫庆,周薇薇,蒋怡然,袁文祺,唐欣,张军妮,戴蒙,宁光.血浆甲氧基肾上腺素和甲氧基去甲肾上腺素诊断嗜铬组织来源肿瘤的意义[J].上海交通大学学报(医学版),2010,30(5):489-492. 被引量:19

二级参考文献50

共引文献43

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部